Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study

Alessandro Armuzzi; Filippo Cremonini; Veronica Ojetti; F Bartolozzi; F Canducci; Marcello Candelli; Luca Santarelli; Giovanni Cammarota; A De Lorenzo; Paolo Pola; Giovanni Battista Gasbarrini; Antonio Gasbarrini

Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study

Alessandro Armuzzi
, Filippo Cremonini
, Veronica Ojetti
, F Bartolozzi
, F Canducci
, Marcello Candelli
, Luca Santarelli
, Giovanni Cammarota
, A De Lorenzo
, Paolo Pola
, Giovanni Battista Gasbarrini
, Antonio Gasbarrini

Risultato della ricerca: Contributo in rivista › Articolo

Abstract

One-week triple therapy is currently regarded as the reference of anti-Helicobacter pylori treatment. However, antibiotic-associated gastrointestinal side effects are among the major pitfalls of such regimens. Probiotic supplementation may be regarded as a therapeutic tool to prevent or reduce these troublesome drug-related manifestations.

Lingua originale	Inglese
pagine (da-a)	1-7
Numero di pagine	7
Rivista	Digestion
Volume	63
Stato di pubblicazione	Pubblicato - 2001

Keywords

2-Pyridinylmethylsulfinylbenzimidazoles
Anti-Bacterial Agents
Anti-Ulcer Agents
Benzimidazoles
Clarithromycin
Diarrhea
Helicobacter Infections
Helicobacter pylori
Lactobacillus
Omeprazole
Pilot Projects
Sulfoxides
Taste Disorders
Tinidazole

OSS delle Nazioni Unite

Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{9cdd2ed151d34ecc85872bf824261c30,

title = "Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study",

abstract = "One-week triple therapy is currently regarded as the reference of anti-Helicobacter pylori treatment. However, antibiotic-associated gastrointestinal side effects are among the major pitfalls of such regimens. Probiotic supplementation may be regarded as a therapeutic tool to prevent or reduce these troublesome drug-related manifestations.",

keywords = "2-Pyridinylmethylsulfinylbenzimidazoles, Anti-Bacterial Agents, Anti-Ulcer Agents, Benzimidazoles, Clarithromycin, Diarrhea, Helicobacter Infections, Helicobacter pylori, Lactobacillus, Omeprazole, Pilot Projects, Sulfoxides, Taste Disorders, Tinidazole, 2-Pyridinylmethylsulfinylbenzimidazoles, Anti-Bacterial Agents, Anti-Ulcer Agents, Benzimidazoles, Clarithromycin, Diarrhea, Helicobacter Infections, Helicobacter pylori, Lactobacillus, Omeprazole, Pilot Projects, Sulfoxides, Taste Disorders, Tinidazole",

author = "Alessandro Armuzzi and Filippo Cremonini and Veronica Ojetti and F Bartolozzi and F Canducci and Marcello Candelli and Luca Santarelli and Giovanni Cammarota and \{De Lorenzo\}, A and Paolo Pola and Gasbarrini, \{Giovanni Battista\} and Antonio Gasbarrini",

year = "2001",

language = "English",

volume = "63",

pages = "1--7",

journal = "Digestion",

issn = "0012-2823",

publisher = "S. Karger AG",

}

TY - JOUR

T1 - Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study

AU - Armuzzi, Alessandro

AU - Cremonini, Filippo

AU - Ojetti, Veronica

AU - Bartolozzi, F

AU - Canducci, F

AU - Candelli, Marcello

AU - Santarelli, Luca

AU - Cammarota, Giovanni

AU - De Lorenzo, A

AU - Pola, Paolo

AU - Gasbarrini, Giovanni Battista

AU - Gasbarrini, Antonio

PY - 2001

Y1 - 2001

N2 - One-week triple therapy is currently regarded as the reference of anti-Helicobacter pylori treatment. However, antibiotic-associated gastrointestinal side effects are among the major pitfalls of such regimens. Probiotic supplementation may be regarded as a therapeutic tool to prevent or reduce these troublesome drug-related manifestations.

AB - One-week triple therapy is currently regarded as the reference of anti-Helicobacter pylori treatment. However, antibiotic-associated gastrointestinal side effects are among the major pitfalls of such regimens. Probiotic supplementation may be regarded as a therapeutic tool to prevent or reduce these troublesome drug-related manifestations.

KW - 2-Pyridinylmethylsulfinylbenzimidazoles

KW - Anti-Bacterial Agents

KW - Anti-Ulcer Agents

KW - Benzimidazoles

KW - Clarithromycin

KW - Diarrhea

KW - Helicobacter Infections

KW - Helicobacter pylori

KW - Lactobacillus

KW - Omeprazole

KW - Pilot Projects

KW - Sulfoxides

KW - Taste Disorders

KW - Tinidazole

KW - 2-Pyridinylmethylsulfinylbenzimidazoles

KW - Anti-Bacterial Agents

KW - Anti-Ulcer Agents

KW - Benzimidazoles

KW - Clarithromycin

KW - Diarrhea

KW - Helicobacter Infections

KW - Helicobacter pylori

KW - Lactobacillus

KW - Omeprazole

KW - Pilot Projects

KW - Sulfoxides

KW - Taste Disorders

KW - Tinidazole

UR - http://hdl.handle.net/10807/19895

M3 - Article

SN - 0012-2823

VL - 63

SP - 1

EP - 7

JO - Digestion

JF - Digestion

ER -

Effect of Lactobacillus GG supplementation on antibiotic-associated gastrointestinal side effects during Helicobacter pylori eradication therapy: a pilot study

Abstract

Keywords

OSS delle Nazioni Unite

Altri file e collegamenti

Fingerprint

Cita questo